Yüklüyor......

Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer’s disease?

Understanding the etiopathological processes of Alzheimer’s disease (AD) in the preclinical and early clinical stages will be important in developing new therapeutic targets and biomarkers. There is growing consensus that nonamyloid targets will be necessary to reverse or slow AD progression. Lipido...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mielke, Michelle M, Haughey, Norman J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3627378/
https://ncbi.nlm.nih.gov/pubmed/23606909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/clp.12.59
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!